| __timestamp | ACADIA Pharmaceuticals Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 4050200000 |
| Thursday, January 1, 2015 | 76369000 | 5047100000 |
| Friday, January 1, 2016 | 4406000 | 6078400000 |
| Sunday, January 1, 2017 | 13060000 | 6931500000 |
| Monday, January 1, 2018 | 18330000 | 6861900000 |
| Tuesday, January 1, 2019 | 19598000 | 7056300000 |
| Wednesday, January 1, 2020 | 20550000 | 8149300000 |
| Friday, January 1, 2021 | 19141000 | 12310800000 |
| Saturday, January 1, 2022 | 10166000 | 9765700000 |
| Sunday, January 1, 2023 | 45731000 | 8988300000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. This chart provides a fascinating comparison between Viatris Inc. and ACADIA Pharmaceuticals Inc. over the past decade. Viatris Inc., a global healthcare company, consistently shows a robust cost of revenue, peaking in 2021 with a staggering 12.3 billion dollars. In contrast, ACADIA Pharmaceuticals, a biopharmaceutical company focused on central nervous system disorders, exhibits a more modest cost structure, with its highest in 2015 at approximately 7.6 million dollars.
From 2014 to 2023, Viatris Inc.'s cost of revenue increased by over 120%, reflecting its expansive operations and market reach. Meanwhile, ACADIA Pharmaceuticals experienced fluctuations, with a notable dip in 2016. This comparison highlights the diverse financial strategies and market positions of these two industry players.
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Viatris Inc.
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
Viatris Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Annual Revenue Comparison: Viatris Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Viatris Inc. vs Vericel Corporation
Viatris Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Grifols, S.A. vs ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored